What is InfuSystem's operating income?

InfuSystem's total operating income in 2025 was $11.92 million, based on the following breakdown: Total Gross Profit: $80.30 million Total Operating Expenses: $68.38 million

InfuSystem (INFU) Financials

$10.16 +0.14 (+1.40%)

Closing price 07/2/2026 04:00 PM Eastern

Extended Trading

$10.15 -0.01 (-0.10%)

As of 07/2/2026 05:39 PM Eastern

Compare

Annual Income Statements for InfuSystem

This table shows InfuSystem's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	2.79	-0.22	-21	-1.10	1.36	17	1.69	1.24	0.47	2.38	6.07
Consolidated Net Income / (Loss)	2.79	-0.22	-21	-1.10	1.36	17	1.42	0.02	0.87	2.35	6.63
Net Income / (Loss) Continuing Operations	2.79	-0.22	-21	-1.10	1.36	17	1.42	0.02	0.87	2.35	6.63
Total Pre-Tax Income	3.99	-0.36	-5.26	-1.04	1.52	7.54	1.26	0.13	1.85	5.06	11
Total Operating Income	7.28	0.97	-3.81	0.42	3.53	8.83	2.82	1.65	4.09	6.89	12
Total Gross Profit	44	39	43	40	47	58	59	61	63	70	80
Total Revenue	71	70	71	67	81	97	102	110	126	135	143
Operating Revenue	71	70	71	67	81	97	102	110	126	135	143
Total Cost of Revenue	26	31	28	28	34	39	44	49	63	64	63
Operating Cost of Revenue	21	26	28	28	34	39	44	49	63	64	63
Total Operating Expenses	37	38	47	39	43	49	56	59	59	64	68
Selling, General & Admin Expense	24	25	25	25	29	35	41	44	45	51	57
Marketing Expense	10	9.66	9.78	9.11	9.93	9.66	11	12	13	11	10
Amortization Expense	2.88	3.85	5.56	4.65	4.40	4.29	4.26	2.49	0.99	0.99	0.92
Total Other Income / (Expense), net	-3.29	-1.34	-1.45	-1.46	-2.00	-1.28	-1.56	-1.52	-2.24	-1.83	-1.30
Interest Expense	3.30	1.34	1.33	1.42	1.90	1.26	1.38	1.40	2.17	1.78	1.30
Other Income / (Expense), net	0.01	0.01	-0.11	-0.04	-0.10	-0.03	-0.19	-0.12	-0.07	-0.06	0.00
Income Tax Expense	1.20	-0.14	15	0.05	0.16	-9.79	-0.16	0.11	0.98	2.71	4.00
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-	-	-	-	-	-	-0.27	-1.22	0.40	-0.03	0.55
Basic Earnings per Share	$0.13	($0.01)	($0.91)	($0.05)	$0.07	$0.86	$0.07	$0.00	$0.04	$0.11	$0.32
Weighted Average Basic Shares Outstanding	22.41M	22.62M	22.74M	21.42M	19.73M	20.11M	20.52M	20.65M	21.02M	21.27M	20.66M
Diluted Earnings per Share	$0.12	($0.01)	($0.91)	($0.05)	$0.07	$0.80	$0.06	$0.00	$0.04	$0.11	$0.31
Weighted Average Diluted Shares Outstanding	22.84M	22.62M	22.74M	21.42M	20.84M	21.72M	22.05M	21.55M	21.65M	21.71M	21.10M
Weighted Average Basic & Diluted Shares Outstanding	22.54M	22.69M	22.74M	21.42M	19.96M	20.34M	20.55M	20.89M	-	21.01M	20.22M

This table shows InfuSystem's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	0.69	-0.33	-1.11	0.72	1.81	0.96	-0.27	2.60	2.26	1.48	1.02
Consolidated Net Income / (Loss)	0.69	0.07	-1.11	0.72	1.81	0.93	-0.27	2.60	2.26	2.04	1.02
Net Income / (Loss) Continuing Operations	0.69	0.07	-1.11	0.72	1.81	0.93	-0.27	2.60	2.26	2.04	1.02
Total Pre-Tax Income	1.12	0.73	-1.30	1.31	2.79	2.26	0.25	3.45	3.43	3.50	1.42
Total Operating Income	1.70	1.25	-0.85	1.86	3.27	2.62	0.62	3.78	3.81	3.71	1.59
Total Gross Profit	16	17	16	17	19	18	19	20	21	20	20
Total Revenue	32	32	32	34	35	34	35	36	36	36	34
Operating Revenue	32	32	32	34	35	34	35	36	36	36	34
Total Cost of Revenue	16	15	16	17	16	16	16	16	16	16	14
Operating Cost of Revenue	16	15	16	17	16	16	16	16	16	16	14
Total Operating Expenses	14	15	17	15	16	16	19	16	17	17	18
Selling, General & Admin Expense	11	11	14	12	13	13	15	13	14	14	15
Marketing Expense	2.73	3.72	3.38	3.04	2.76	2.14	2.99	2.70	2.37	2.43	3.08
Amortization Expense	0.25	0.25	0.25	0.25	0.25	0.25	0.25	0.25	0.21	0.21	0.21
Total Other Income / (Expense), net	-0.58	-0.52	-0.45	-0.55	-0.48	-0.35	-0.37	-0.33	-0.38	-0.22	-0.17
Interest Expense	0.56	0.50	0.46	0.48	0.48	0.36	0.34	0.37	0.33	0.26	0.26
Other Income / (Expense), net	-0.01	-0.02	0.00	-0.06	-0.00	0.01	-0.03	0.04	-0.05	0.04	0.08
Income Tax Expense	0.43	0.66	-0.19	0.59	0.98	1.33	0.52	0.85	1.17	1.46	0.40
Basic Earnings per Share	$0.03	$0.01	($0.05)	$0.03	$0.08	$0.05	($0.01)	$0.12	$0.11	$0.10	$0.05
Weighted Average Basic Shares Outstanding	21.10M	21.02M	21.23M	21.30M	21.29M	21.27M	21.13M	20.81M	20.41M	20.66M	20.21M
Diluted Earnings per Share	$0.03	$0.01	($0.05)	$0.03	$0.08	$0.05	($0.01)	$0.12	$0.11	$0.09	$0.05
Weighted Average Diluted Shares Outstanding	21.72M	21.65M	21.23M	21.71M	21.65M	21.71M	21.13M	21.06M	20.95M	21.10M	20.89M
Weighted Average Basic & Diluted Shares Outstanding	21.18M	0.00	21.30M	21.32M	21.26M	21.01M	20.98M	20.43M	20.34M	20.22M	20.18M

This table details how cash moves in and out of InfuSystem's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	0.30	2.58	0.07	0.85	-1.67	7.00	-9.46	-0.02	0.07	0.30	2.66
Net Cash From Operating Activities	7.05	7.91	7.72	11	14	20	18	18	11	20	24
Net Cash From Continuing Operating Activities	7.05	7.91	7.72	11	14	20	18	18	11	20	24
Net Income / (Loss) Continuing Operations	2.79	-0.22	-21	-1.10	1.36	17	1.42	0.02	0.87	2.35	6.63
Consolidated Net Income / (Loss)	2.79	-0.22	-21	-1.10	1.36	17	1.42	0.02	0.87	2.35	6.63
Depreciation Expense	5.36	6.90	6.96	6.66	7.94	9.74	10	11	12	12	12
Amortization Expense	3.01	3.88	5.59	4.68	4.44	4.30	4.41	2.57	1.11	1.07	1.00
Non-Cash Adjustments To Reconcile Net Income	5.98	5.50	5.86	-0.17	0.22	0.24	4.97	3.66	2.65	2.97	1.77
Changes in Operating Assets and Liabilities, net	-10	-8.15	10	1.31	-0.08	-11	-2.85	0.40	-4.93	2.57	2.63
Net Cash From Investing Activities	-12	-5.34	0.92	-4.98	-20	-12	-21	-11	-6.73	-13	-6.79
Net Cash From Continuing Investing Activities	-12	-5.34	0.92	-4.98	-20	-12	-21	-11	-6.73	-13	-6.79
Purchase of Property, Plant & Equipment	-4.51	-5.27	-2.76	-0.28	-2.93	-1.09	-0.98	-0.98	-1.02	-1.09	-0.56
Acquisitions	-12	-3.90	-0.19	-	0.00	0.00	-7.98	0.00	-	0.00	-1.41
Sale of Property, Plant & Equipment	4.49	3.82	3.87	3.32	2.95	4.75	3.32	3.60	4.38	4.59	3.31
Other Investing Activities, net	-	-	-	-8.02	-20	-16	-16	-14	-10	-17	-8.13
Net Cash From Financing Activities	5.16	0.02	-8.57	-5.56	4.10	-1.12	-6.46	-6.06	-4.42	-6.92	-15
Net Cash From Continuing Financing Activities	5.16	0.02	-8.57	-5.56	4.10	-1.12	-6.46	-6.06	-4.42	-6.92	-15
Repayment of Debt	-65	-67	-38	-6.35	-4.87	-37	-82	-42	-56	-56	-53
Repurchase of Common Equity	-0.18	-	0.00	-10	0.00	0.00	-0.56	-5.46	-0.15	-1.18	-9.87
Issuance of Debt	70	67	29	11	9.44	38	76	42	52	51	48
Issuance of Common Equity	0.27	0.20	0.13	0.09	0.25	0.19	1.12	1.36	1.06	0.39	0.34
Other Financing Activities, net	-	-0.08	-0.06	-0.07	-0.72	-1.71	-1.17	-1.94	-1.16	-0.82	-1.11
Cash Interest Paid	1.51	1.23	1.20	1.38	1.71	1.21	1.11	1.31	2.05	1.75	1.24
Cash Income Taxes Paid	0.15	0.11	0.14	0.16	0.11	0.10	0.17	0.15	0.21	0.75	0.54

This table details how cash moves in and out of InfuSystem's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	0.03	0.07	0.59	-0.68	0.23	0.15	0.98	-0.79	0.24	2.23	-1.08
Net Cash From Operating Activities	4.26	4.66	0.38	2.31	9.84	7.93	1.78	7.01	8.49	7.13	0.97
Net Cash From Continuing Operating Activities	4.26	4.66	0.38	2.31	9.84	7.93	1.78	7.01	8.49	7.13	0.97
Net Income / (Loss) Continuing Operations	0.69	0.07	-1.11	0.72	1.81	0.93	-0.27	2.60	2.26	2.04	1.02
Consolidated Net Income / (Loss)	0.69	0.07	-1.11	0.72	1.81	0.93	-0.27	2.60	2.26	2.04	1.02
Depreciation Expense	2.82	2.90	2.65	2.79	2.90	3.17	3.07	3.09	3.07	3.14	3.04
Amortization Expense	0.27	0.27	0.27	0.27	0.27	0.27	0.27	0.27	0.24	0.23	0.23
Non-Cash Adjustments To Reconcile Net Income	0.76	0.69	0.26	0.89	0.81	1.02	0.57	-0.11	0.78	0.53	1.63
Changes in Operating Assets and Liabilities, net	-0.27	0.73	-1.69	-2.35	4.06	2.54	-1.86	1.16	2.15	1.20	-4.95
Net Cash From Investing Activities	-0.30	-1.04	-0.42	-6.70	-2.86	-3.27	-2.66	-1.69	-0.25	-2.19	-1.26
Net Cash From Continuing Investing Activities	-0.30	-1.04	-0.42	-6.70	-2.86	-3.27	-2.66	-1.69	-0.25	-2.19	-1.26
Purchase of Property, Plant & Equipment	-0.12	-0.41	-0.18	-0.34	-0.04	-0.53	-0.13	-0.22	-0.08	-0.13	-0.16
Sale of Property, Plant & Equipment	1.33	0.95	1.26	0.94	0.55	1.84	0.75	0.97	0.85	0.73	0.58
Other Investing Activities, net	-1.51	-1.59	-1.49	-7.30	-3.37	-4.58	-3.28	-1.03	-1.03	-2.79	-1.68
Net Cash From Financing Activities	-3.94	-3.54	0.63	3.71	-6.75	-4.52	1.86	-6.11	-8.01	-2.70	-0.79
Net Cash From Continuing Financing Activities	-3.94	-3.54	0.63	3.71	-6.75	-4.52	1.86	-6.11	-8.01	-2.70	-0.79
Repayment of Debt	-14	-12	-15	-11	-14	-16	-14	-16	-14	-8.05	-6.15
Repurchase of Common Equity	-	-	0.00	-0.28	-0.70	-0.20	-2.90	-3.50	-2.17	-1.31	-0.81
Issuance of Debt	10	8.76	16	16	7.46	12	19	13	8.79	6.72	6.15
Issuance of Common Equity	0.20	0.03	0.19	0.04	0.16	0.01	0.16	-	0.18	-0.00	0.18
Other Financing Activities, net	-0.63	-0.00	-0.37	-0.26	-0.00	-0.19	-0.23	-0.23	-0.58	-0.07	-0.17

This table presents InfuSystem's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	95	96	69	64	79	97	98	99	103	104	101
Total Current Assets	19	21	18	18	19	30	22	25	31	32	36
Cash & Equivalents	0.82	3.40	3.47	4.32	2.65	9.65	0.19	0.17	0.23	0.53	3.19
Accounts Receivable	13	12	11	9.59	12	15	15	17	20	21	23
Inventories, net	1.92	2.17	1.76	2.25	2.90	3.00	3.94	4.82	6.40	6.53	5.39
Other Current Assets	0.86	0.95	1.15	1.37	1.66	2.40	2.54	2.92	4.16	3.96	4.86
Plant, Property, & Equipment, net	2.37	2.00	1.63	1.45	4.04	4.30	4.52	4.39	4.32	4.03	3.36
Total Noncurrent Assets	74	74	50	45	56	63	71	70	68	67	61
Goodwill	-	-	-	-	-	0.00	3.71	3.71	3.71	3.71	3.71
Intangible Assets	32	31	25	20	15	11	11	8.44	7.45	6.46	6.87
Noncurrent Deferred & Refundable Income Taxes	12	12	-	-	0.00	9.97	10	9.63	9.12	7.19	4.64
Other Noncurrent Operating Assets	30	30	25	25	40	42	46	48	48	50	46
Total Liabilities & Shareholders' Equity	95	96	69	64	79	97	98	99	103	104	101
Total Liabilities	45	46	38	44	57	56	49	51	51	46	43
Total Current Liabilities	15	16	12	15	22	23	13	14	16	18	20
Accounts Payable	6.59	5.32	5.52	7.09	7.96	6.78	7.86	8.34	8.01	9.85	11
Other Current Liabilities	3.64	2.87	3.41	2.80	5.80	6.80	4.69	6.13	7.70	7.81	9.36
Total Noncurrent Liabilities	30	29	25	29	35	33	36	37	35	28	23
Long-Term Debt	27	27	25	29	30	29	33	33	29	24	20
Other Noncurrent Operating Liabilities	-	0.07	0.01	0.00	4.64	3.86	3.67	3.76	5.80	4.56	3.43
Total Equity & Noncontrolling Interests	50	51	31	20	22	41	48	48	52	58	57
Total Preferred & Common Equity	50	51	31	20	22	41	48	48	52	58	57
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	50	51	31	20	22	41	48	48	52	58	57
Common Stock	91	92	93	83	84	85	102	106	110	114	117
Retained Earnings	-41	-41	-62	-63	-61	-44	-54	-59	-59	-57	-61
Accumulated Other Comprehensive Income / (Loss)	-	-	-	-	-	0.00	0.27	1.49	1.09	1.12	0.57

This table presents InfuSystem's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	102	105	109	105	104	101	99	99
Total Current Assets	30	32	33	34	35	35	36	37
Cash & Equivalents	0.16	0.82	0.15	0.38	1.51	0.72	0.96	2.11
Accounts Receivable	19	21	21	23	24	24	24	24
Inventories, net	6.09	6.25	6.84	6.70	6.10	5.67	5.59	5.83
Other Current Assets	4.01	4.84	4.60	3.77	3.83	3.93	4.72	4.74
Plant, Property, & Equipment, net	4.23	4.23	4.17	3.91	3.92	3.81	3.65	3.22
Total Noncurrent Assets	68	68	71	68	65	62	60	59
Goodwill	3.71	3.71	3.71	3.71	3.71	3.71	3.71	3.71
Intangible Assets	7.69	7.20	6.95	6.70	6.21	7.15	7.08	6.66
Noncurrent Deferred & Refundable Income Taxes	9.25	9.24	8.64	7.82	6.75	5.96	4.81	4.23
Other Noncurrent Operating Assets	47	48	52	50	48	45	44	44
Total Liabilities & Shareholders' Equity	102	105	109	105	104	101	99	99
Total Liabilities	51	53	55	50	49	46	43	40
Total Current Liabilities	14	17	16	17	16	16	19	17
Accounts Payable	7.63	9.80	9.94	8.91	8.37	9.32	10	9.63
Other Current Liabilities	6.65	7.52	5.94	8.03	7.60	6.54	8.69	7.51
Total Noncurrent Liabilities	36	35	39	33	33	30	25	23
Long-Term Debt	33	30	34	28	29	26	21	20
Other Noncurrent Operating Liabilities	3.67	5.33	5.00	4.88	4.46	4.11	3.76	3.12
Total Equity & Noncontrolling Interests	51	52	53	56	55	55	55	59
Total Preferred & Common Equity	51	52	53	56	55	55	55	59
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	51	52	53	56	55	55	55	59
Common Stock	109	111	111	113	115	115	116	119
Retained Earnings	-59	-60	-59	-58	-61	-62	-61	-61
Accumulated Other Comprehensive Income / (Loss)	1.63	1.30	1.30	0.84	0.87	0.72	0.64	0.58

This table displays calculated financial ratios and metrics derived from InfuSystem's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	22,514,484.00	22,669,675.00	22,780,738.00	19,542,465.00	19,843,021.00	20,236,932.00	20,649,447.00	20,656,374.00	21,183,526.00	-	20,336,183.00
DEI Adjusted Shares Outstanding	22,514,484.00	22,669,675.00	22,780,738.00	19,542,465.00	19,843,021.00	20,236,932.00	20,649,447.00	20,656,374.00	21,183,526.00	-	20,336,183.00
DEI Earnings Per Adjusted Shares Outstanding	0.12	-0.01	-0.91	-0.06	0.07	0.86	0.08	0.06	0.02	-	0.30
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	6.10%	-0.06%	0.82%	-5.54%	20.82%	20.06%	5.13%	7.36%	14.44%	7.22%	6.36%
EBITDA Growth	-2.77%	-24.95%	-26.62%	35.86%	34.88%	44.49%	-23.77%	-14.04%	11.25%	16.60%	30.31%
EBIT Growth	-21.95%	-86.56%	-500.51%	109.63%	806.88%	156.65%	-70.06%	-41.84%	162.47%	70.01%	74.40%
NOPAT Growth	0.76%	-86.59%	-491.38%	110.89%	983.64%	544.30%	-84.29%	-92.81%	740.92%	65.86%	132.80%
Net Income Growth	-17.04%	-107.97%	-9,227.48%	94.71%	224.29%	1,173.48%	-91.81%	-98.73%	4,744.44%	168.92%	182.60%
EPS Growth	-20.00%	-108.33%	-9,000.00%	94.51%	240.00%	1,042.86%	-92.50%	-100.00%	0.00%	175.00%	181.82%
Operating Cash Flow Growth	-2.77%	12.12%	-2.42%	47.59%	21.81%	46.16%	-9.68%	-4.36%	-35.93%	82.30%	19.30%
Free Cash Flow Firm Growth	-786.07%	103.34%	8,414.49%	-73.31%	-173.85%	267.22%	-195.87%	105.15%	319.37%	100.14%	315.32%
Invested Capital Growth	20.06%	0.45%	-33.39%	-11.60%	16.44%	20.39%	16.13%	-0.23%	0.22%	-0.38%	-8.78%
Revenue Q/Q Growth	3.65%	-2.61%	2.95%	-1.94%	5.39%	3.18%	1.80%	2.15%	2.39%	1.56%	1.69%
EBITDA Q/Q Growth	51.98%	56.90%	299.72%	204.63%	135.43%	-0.08%	4.05%	-7.10%	1.82%	9.42%	4.37%
EBIT Q/Q Growth	-3.61%	-74.97%	-27.39%	136.24%	52.29%	-2.86%	25.79%	-27.80%	6.74%	25.64%	10.49%
NOPAT Q/Q Growth	9.67%	-73.95%	-29.00%	140.61%	80.01%	125.91%	-88.55%	-76.60%	-8.08%	37.21%	16.80%
Net Income Q/Q Growth	21.25%	-112.51%	-550.14%	94.18%	384.34%	132.11%	-87.87%	-93.96%	-3.86%	58.02%	19.97%
EPS Q/Q Growth	20.00%	-114.29%	0.00%	0.00%	600.00%	122.22%	-88.89%	0.00%	0.00%	57.14%	14.81%
Operating Cash Flow Q/Q Growth	-2.77%	12.12%	-35.74%	-3.68%	9.12%	19.23%	-17.56%	5.13%	0.83%	19.04%	-3.19%
Free Cash Flow Firm Q/Q Growth	-118.57%	100.50%	198.94%	-74.72%	-29.36%	218.79%	-162.87%	111.15%	4,600.88%	9.97%	3.64%
Invested Capital Q/Q Growth	223.64%	-4.46%	-27.69%	-0.78%	3.85%	12.31%	5.18%	-1.11%	-3.32%	-2.70%	-2.23%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	62.89%	55.48%	61.01%	58.94%	57.80%	59.52%	57.17%	55.10%	50.17%	52.20%	55.98%
EBITDA Margin	22.20%	16.67%	12.14%	17.46%	19.49%	23.45%	17.00%	13.62%	13.24%	14.39%	17.64%
Operating Margin	10.32%	1.38%	-5.36%	0.62%	4.35%	9.06%	2.75%	1.50%	3.25%	5.11%	8.31%
EBIT Margin	10.34%	1.39%	-5.52%	0.56%	4.23%	9.03%	2.57%	1.39%	3.20%	5.07%	8.31%
Profit (Net Income) Margin	3.95%	-0.31%	-29.13%	-1.63%	1.68%	17.80%	1.39%	0.02%	0.69%	1.74%	4.62%
Tax Burden Percent	69.82%	60.99%	393.89%	105.09%	89.30%	229.78%	112.97%	13.85%	47.11%	46.35%	62.38%
Interest Burden Percent	54.70%	-37.14%	133.94%	-275.66%	44.46%	85.74%	47.72%	8.49%	46.03%	74.01%	89.10%
Effective Tax Rate	30.18%	0.00%	0.00%	0.00%	10.70%	-129.78%	-12.97%	86.15%	52.89%	53.65%	37.62%
Return on Invested Capital (ROIC)	6.58%	0.81%	-3.78%	0.55%	5.83%	31.70%	4.22%	0.28%	2.38%	3.94%	9.62%
ROIC Less NNEP Spread (ROIC-NNEP)	-1.38%	-1.85%	-64.45%	-4.50%	0.35%	22.60%	-1.47%	-0.36%	-1.03%	0.69%	5.55%
Return on Net Nonoperating Assets (RNNOA)	-0.82%	-1.25%	-46.94%	-4.81%	0.53%	23.25%	-1.03%	-0.25%	-0.64%	0.33%	1.92%
Return on Equity (ROE)	5.76%	-0.44%	-50.73%	-4.26%	6.36%	54.95%	3.19%	0.04%	1.74%	4.27%	11.54%
Cash Return on Invested Capital (CROIC)	-11.65%	0.36%	36.30%	12.86%	-9.35%	13.19%	-10.71%	0.51%	2.16%	4.32%	18.80%
Operating Return on Assets (OROA)	8.31%	1.02%	-4.75%	0.57%	4.78%	9.99%	2.71%	1.56%	3.98%	6.62%	11.68%
Return on Assets (ROA)	3.17%	-0.23%	-25.07%	-1.65%	1.90%	19.67%	1.46%	0.02%	0.86%	2.27%	6.49%
Return on Common Equity (ROCE)	5.76%	-0.44%	-50.73%	-4.26%	6.36%	54.95%	3.19%	0.04%	1.74%	4.27%	11.54%
Return on Equity Simple (ROE_SIMPLE)	5.53%	-0.44%	-66.90%	-5.36%	6.09%	42.53%	2.94%	0.04%	1.67%	4.08%	0.00%
Net Operating Profit after Tax (NOPAT)	5.08	0.68	-2.67	0.29	3.15	20	3.19	0.23	1.93	3.19	7.44
NOPAT Margin	7.21%	0.97%	-3.75%	0.43%	3.88%	20.83%	3.11%	0.21%	1.53%	2.37%	5.18%
Net Nonoperating Expense Percent (NNEP)	7.96%	2.66%	60.67%	5.05%	5.49%	9.09%	5.69%	0.64%	3.41%	3.25%	4.07%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	2.37%	3.92%	9.66%
Cost of Revenue to Revenue	37.11%	44.52%	38.99%	41.06%	42.20%	40.48%	42.83%	44.90%	49.83%	47.80%	44.02%
SG&A Expenses to Revenue	33.71%	34.94%	35.49%	37.83%	35.73%	36.14%	39.73%	40.17%	36.08%	37.97%	39.72%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	52.57%	54.09%	66.37%	58.32%	53.45%	50.46%	54.42%	53.59%	46.92%	47.09%	47.67%
Earnings before Interest and Taxes (EBIT)	7.29	0.98	-3.93	0.38	3.43	8.80	2.63	1.53	4.02	6.84	12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	16	12	8.63	12	16	23	17	15	17	19	25
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.35	1.14	1.69	3.29	7.58	9.33	7.29	3.74	4.27	3.12	3.18
Price to Tangible Book Value (P/TBV)	3.62	2.97	8.14	116.71	24.63	12.85	10.46	5.00	5.43	3.79	3.90
Price to Revenue (P/Rev)	0.96	0.82	0.74	1.00	2.09	3.90	3.43	1.63	1.78	1.33	1.27
Price to Earnings (P/E)	24.41	0.00	0.00	0.00	124.37	21.93	208.33	144.71	474.04	75.62	30.04
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	4.10%	0.00%	0.00%	0.00%	0.80%	4.56%	0.48%	0.69%	0.21%	1.32%	3.33%
Enterprise Value to Invested Capital (EV/IC)	1.21	1.08	1.38	1.94	3.53	5.85	4.74	2.62	3.11	2.51	2.70
Enterprise Value to Revenue (EV/Rev)	1.45	1.30	1.10	1.44	2.53	4.20	3.76	1.93	2.00	1.51	1.39
Enterprise Value to EBITDA (EV/EBITDA)	6.51	7.81	9.03	8.25	12.97	17.92	22.09	14.19	15.14	10.46	7.86
Enterprise Value to EBIT (EV/EBIT)	13.98	93.69	0.00	255.70	59.80	46.51	146.00	138.57	62.71	29.70	16.68
Enterprise Value to NOPAT (EV/NOPAT)	20.07	134.66	0.00	332.71	65.12	20.18	120.72	926.97	130.93	63.56	26.74
Enterprise Value to Operating Cash Flow (EV/OCF)	14.46	11.61	10.09	8.49	14.77	20.18	21.00	12.12	22.47	9.92	8.15
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	305.23	3.04	14.14	0.00	48.48	0.00	509.07	144.18	58.00	13.68
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.69	0.74	0.93	1.65	1.72	0.95	0.69	0.69	0.56	0.41	0.34
Long-Term Debt to Equity	0.59	0.58	0.82	1.41	1.36	0.72	0.68	0.69	0.56	0.41	0.34
Financial Leverage	0.60	0.67	0.73	1.07	1.52	1.03	0.70	0.68	0.62	0.48	0.35
Leverage Ratio	1.81	1.90	2.02	2.59	3.35	2.79	2.19	2.05	2.02	1.88	1.78
Compound Leverage Factor	0.99	-0.70	2.71	-7.13	1.49	2.39	1.04	0.17	0.93	1.39	1.58
Debt to Total Capital	40.89%	42.46%	48.31%	62.28%	63.21%	48.77%	40.68%	40.85%	35.75%	29.32%	25.50%
Short-Term Debt to Total Capital	5.91%	9.37%	5.92%	9.05%	13.31%	11.84%	0.43%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	34.98%	33.09%	42.39%	53.23%	49.90%	36.93%	40.25%	40.85%	35.75%	29.32%	25.50%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	59.11%	57.54%	51.69%	37.72%	36.79%	51.23%	59.32%	59.15%	64.25%	70.68%	74.50%
Debt to EBITDA	2.22	3.18	3.35	2.88	2.43	1.70	1.90	2.22	1.75	1.23	0.78
Net Debt to EBITDA	2.17	2.89	2.95	2.51	2.26	1.28	1.89	2.20	1.73	1.20	0.65
Long-Term Debt to EBITDA	1.90	2.48	2.94	2.46	1.92	1.29	1.88	2.22	1.75	1.23	0.78
Debt to NOPAT	6.85	54.86	-10.84	116.16	12.19	1.91	10.39	144.78	15.11	7.47	2.64
Net Debt to NOPAT	6.69	49.87	-9.54	101.30	11.35	1.44	10.33	144.06	14.99	7.31	2.21
Long-Term Debt to NOPAT	5.86	42.75	-9.51	99.28	9.62	1.45	10.28	144.78	15.11	7.47	2.64
Altman Z-Score	1.34	0.98	0.51	0.67	1.83	4.81	4.76	2.54	3.37	3.25	3.70
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.24	1.26	1.42	1.19	0.88	1.29	1.71	1.71	1.95	1.82	1.80
Quick Ratio	0.88	0.91	1.18	0.94	0.67	1.06	1.21	1.18	1.28	1.23	1.29
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-9.00	0.30	26	6.84	-5.05	8.44	-8.09	0.42	1.75	3.50	15
Operating Cash Flow to CapEx	39,188.89%	546.20%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	-2.72	0.22	19.23	4.81	-2.65	6.73	-5.88	0.30	0.81	1.97	11.19
Operating Cash Flow to Interest Expense	2.14	5.88	5.79	8.02	7.29	16.16	13.30	12.49	5.17	11.51	18.79
Operating Cash Flow Less CapEx to Interest Expense	2.13	4.81	6.63	10.16	7.30	19.07	15.00	14.36	6.72	13.48	20.91
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.80	0.74	0.86	1.01	1.13	1.11	1.05	1.12	1.24	1.31	1.41
Accounts Receivable Turnover	6.15	5.83	6.22	6.43	7.48	7.26	6.80	6.81	6.85	6.58	6.51
Inventory Turnover	14.25	15.38	14.10	13.72	13.29	13.36	12.64	11.27	11.17	9.97	10.59
Fixed Asset Turnover	29.26	32.29	39.16	43.62	29.59	23.37	23.22	24.68	28.90	32.30	38.82
Accounts Payable Turnover	4.44	5.27	5.12	4.37	4.55	5.35	5.99	6.09	7.67	7.22	6.11
Days Sales Outstanding (DSO)	59.30	62.66	58.71	56.75	48.80	50.25	53.70	53.59	53.25	55.46	56.05
Days Inventory Outstanding (DIO)	25.62	23.73	25.88	26.60	27.47	27.31	28.89	32.39	32.68	36.61	34.45
Days Payable Outstanding (DPO)	82.28	69.20	71.32	83.46	80.25	68.25	60.94	59.92	47.61	50.56	59.74
Cash Conversion Cycle (CCC)	2.64	17.19	13.27	-0.11	-3.98	9.32	21.65	26.07	38.32	41.51	30.76
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	84	85	56	50	58	70	81	81	81	81	74
Invested Capital Turnover	0.91	0.83	1.01	1.26	1.50	1.52	1.36	1.36	1.55	1.66	1.86
Increase / (Decrease) in Invested Capital	14	0.38	-28	-6.55	8.20	12	11	-0.19	0.18	-0.31	-7.10
Enterprise Value (EV)	102	92	78	97	205	409	385	212	252	203	199
Market Capitalization	68	58	52	67	169	380	352	179	223	180	182
Book Value per Share	$2.24	$2.24	$1.36	$1.05	$1.13	$2.01	$2.34	$2.32	$2.47	$2.71	$2.82
Tangible Book Value per Share	$0.83	$0.86	$0.28	$0.03	$0.35	$1.46	$1.63	$1.74	$1.94	$2.23	$2.30
Total Capital	85	88	60	54	61	80	81	81	81	81	77
Total Debt	35	37	29	34	38	39	33	33	29	24	20
Total Long-Term Debt	30	29	25	29	30	29	33	33	29	24	20
Net Debt	34	34	25	29	36	29	33	33	29	23	16
Capital Expenditures (CapEx)	0.02	1.45	-1.11	-3.04	-0.03	-3.66	-2.34	-2.62	-3.36	-3.50	-2.75
Debt-free, Cash-free Net Working Capital (DFCFNWC)	7.92	9.18	5.27	3.33	2.89	6.55	9.33	10	15	14	13
Debt-free Net Working Capital (DFNWC)	8.73	13	8.74	7.65	5.54	16	9.52	10	15	15	16
Net Working Capital (NWC)	3.70	4.33	5.19	2.75	-2.54	6.77	9.17	10	15	15	16
Net Nonoperating Expense (NNE)	2.30	0.90	18	1.39	1.79	2.95	1.77	0.21	1.05	0.85	0.81
Net Nonoperating Obligations (NNO)	34	34	25	29	36	29	33	33	29	23	16
Total Depreciation and Amortization (D&A)	8.37	11	13	11	12	14	15	13	13	13	13
Debt-free, Cash-free Net Working Capital to Revenue	11.22%	13.03%	7.41%	4.96%	3.57%	6.72%	9.11%	9.23%	11.67%	10.36%	9.04%
Debt-free Net Working Capital to Revenue	12.38%	17.85%	12.29%	11.39%	6.83%	16.63%	9.30%	9.38%	11.85%	10.75%	11.26%
Net Working Capital to Revenue	5.25%	6.14%	7.31%	4.09%	-3.13%	6.96%	8.96%	9.38%	11.85%	10.75%	11.26%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.17	($0.01)	($0.91)	($0.05)	$0.07	$0.86	$0.07	$0.00	$0.04	$0.11	$0.32
Adjusted Weighted Average Basic Shares Outstanding	22.41M	22.62M	22.74M	19.58M	19.73M	20.11M	20.52M	20.65M	21.02M	21.27M	20.66M
Adjusted Diluted Earnings per Share	$0.16	($0.01)	($0.91)	($0.05)	$0.07	$0.80	$0.06	$0.00	$0.04	$0.11	$0.31
Adjusted Weighted Average Diluted Shares Outstanding	22.84M	22.62M	22.74M	19.58M	20.84M	21.72M	22.05M	21.55M	21.65M	21.71M	21.10M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	($0.05)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	22.54M	22.69M	22.81M	21.42M	19.96M	20.34M	20.55M	20.89M	0.00	21.01M	20.22M
Normalized Net Operating Profit after Tax (NOPAT)	5.08	0.68	-1.97	0.29	3.15	6.18	1.97	1.16	2.86	4.82	7.44
Normalized NOPAT Margin	7.21%	0.97%	-2.78%	0.43%	3.88%	6.34%	1.93%	1.05%	2.28%	3.58%	5.18%
Pre Tax Income Margin	5.65%	-0.52%	-7.40%	-1.55%	1.88%	7.75%	1.23%	0.12%	1.47%	3.75%	7.41%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.21	0.73	-2.95	0.27	1.80	7.01	1.91	1.09	1.85	3.85	9.18
NOPAT to Interest Expense	1.54	0.51	-2.00	0.20	1.65	16.16	2.31	0.16	0.89	1.80	5.72
EBIT Less CapEx to Interest Expense	2.20	-0.35	-2.11	2.41	1.81	9.93	3.61	2.96	3.40	5.82	11.29
NOPAT Less CapEx to Interest Expense	1.53	-0.57	-1.17	2.34	1.67	19.08	4.01	2.03	2.44	3.77	7.84
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	6.43%	0.00%	0.00%	-949.32%	0.00%	0.00%	39.44%	30,327.78%	17.55%	50.32%	148.92%

This table displays calculated financial ratios and metrics derived from InfuSystem's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	21,054,756.00	21,183,526.00	21,183,526.00	21,295,254.00	21,315,428.00	-	21,009,216.00	20,975,264.00	20,425,964.00	20,336,183.00	20,215,159.00
DEI Adjusted Shares Outstanding	21,054,756.00	21,183,526.00	21,183,526.00	21,295,254.00	21,315,428.00	-	21,009,216.00	20,975,264.00	20,425,964.00	20,336,183.00	20,215,159.00
DEI Earnings Per Adjusted Shares Outstanding	0.03	-0.02	-0.05	0.03	0.08	-	-0.01	0.12	0.11	0.07	0.05
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	16.97%	10.20%	5.35%	6.19%	10.69%	6.54%	8.50%	6.84%	3.31%	7.04%	-2.97%
EBITDA Growth	8.70%	7.25%	-32.54%	10.04%	34.64%	38.02%	89.12%	48.19%	9.93%	17.47%	25.92%
EBIT Growth	80.58%	26.02%	-492.96%	43.36%	93.76%	113.41%	169.95%	113.11%	15.21%	43.12%	183.87%
NOPAT Growth	36.70%	-38.16%	-689.72%	18.00%	102.92%	770.83%	-10.26%	180.14%	18.58%	100.58%	274.97%
Net Income Growth	55.53%	-32.71%	-243.21%	64.83%	162.26%	1,195.83%	75.99%	262.48%	25.01%	118.22%	480.90%
EPS Growth	50.00%	0.00%	-150.00%	50.00%	166.67%	400.00%	80.00%	300.00%	37.50%	80.00%	600.00%
Operating Cash Flow Growth	23.38%	2.01%	349.67%	-5.83%	130.82%	70.27%	372.15%	203.55%	-13.71%	-10.15%	-45.51%
Free Cash Flow Firm Growth	74.37%	-113.71%	162.39%	89.92%	393.23%	2,701.44%	-166.94%	2,033.71%	242.10%	569.29%	545.56%
Invested Capital Growth	2.51%	0.22%	-3.56%	1.80%	-1.02%	-0.38%	1.18%	-8.39%	-9.22%	-8.78%	-7.36%
Revenue Q/Q Growth	0.55%	-0.43%	0.71%	5.32%	4.81%	-4.17%	2.56%	3.70%	1.35%	-0.71%	-7.03%
EBITDA Q/Q Growth	8.38%	-7.90%	-52.74%	133.27%	32.61%	-5.59%	-35.25%	82.79%	-1.63%	0.89%	-30.59%
EBIT Q/Q Growth	34.64%	-26.92%	-168.46%	312.83%	81.98%	-19.50%	-77.56%	548.39%	-1.62%	0.00%	-55.50%
NOPAT Q/Q Growth	21.15%	-88.14%	-577.80%	271.91%	108.33%	-49.11%	-160.50%	536.78%	-11.81%	-13.92%	-47.23%
Net Income Q/Q Growth	58.39%	-89.55%	-1,644.44%	164.48%	152.02%	-48.37%	-128.62%	1,073.41%	-13.08%	-9.87%	-50.05%
EPS Q/Q Growth	50.00%	-66.67%	-600.00%	160.00%	166.67%	-37.50%	-120.00%	1,300.00%	-8.33%	-18.18%	-44.44%
Operating Cash Flow Q/Q Growth	73.90%	9.24%	-91.91%	512.47%	326.25%	-19.42%	-77.56%	293.76%	21.17%	-16.10%	-86.39%
Free Cash Flow Firm Q/Q Growth	80.60%	94.75%	4,638.23%	-121.83%	664.06%	-53.45%	-216.77%	730.72%	-0.21%	-8.93%	-22.26%
Invested Capital Q/Q Growth	-2.33%	-3.32%	0.26%	7.52%	-5.03%	-2.70%	1.83%	-2.66%	-5.88%	-2.23%	3.42%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	48.94%	52.60%	51.49%	49.46%	53.92%	53.82%	55.21%	55.20%	57.06%	56.40%	58.43%
EBITDA Margin	14.96%	13.83%	6.49%	14.38%	18.19%	17.92%	11.31%	19.94%	19.36%	19.67%	14.68%
Operating Margin	5.32%	3.93%	-2.64%	5.50%	9.24%	7.73%	1.78%	10.49%	10.44%	10.25%	4.72%
EBIT Margin	5.27%	3.87%	-2.63%	5.32%	9.23%	7.76%	1.70%	10.61%	10.30%	10.37%	4.96%
Profit (Net Income) Margin	2.16%	0.23%	-3.48%	2.13%	5.12%	2.76%	-0.77%	7.22%	6.19%	5.62%	3.02%
Tax Burden Percent	61.52%	9.90%	85.67%	54.82%	64.88%	41.21%	-105.53%	75.42%	65.92%	58.22%	71.77%
Interest Burden Percent	66.55%	59.11%	154.16%	72.99%	85.40%	86.25%	42.95%	90.23%	91.22%	93.08%	84.75%
Effective Tax Rate	38.48%	90.10%	0.00%	45.18%	35.12%	58.79%	205.53%	24.58%	34.08%	41.78%	28.23%
Return on Invested Capital (ROIC)	4.85%	0.60%	-2.84%	4.50%	9.53%	5.30%	-3.16%	13.20%	12.25%	11.07%	6.08%
ROIC Less NNEP Spread (ROIC-NNEP)	3.78%	0.44%	-4.44%	3.64%	8.50%	4.75%	-1.79%	12.37%	11.19%	10.44%	5.53%
Return on Net Nonoperating Assets (RNNOA)	2.54%	0.27%	-2.88%	2.47%	4.77%	2.26%	-0.94%	6.83%	4.79%	3.61%	2.17%
Return on Equity (ROE)	7.38%	0.87%	-5.72%	6.97%	14.31%	7.56%	-4.10%	20.03%	17.04%	14.69%	8.25%
Cash Return on Invested Capital (CROIC)	0.04%	2.16%	3.91%	-0.88%	3.81%	4.32%	3.75%	15.87%	17.69%	18.80%	18.55%
Operating Return on Assets (OROA)	6.45%	4.81%	-3.24%	6.51%	11.82%	10.13%	2.23%	14.17%	14.23%	14.57%	6.97%
Return on Assets (ROA)	2.64%	0.28%	-4.28%	2.61%	6.55%	3.60%	-1.01%	9.65%	8.55%	7.90%	4.24%
Return on Common Equity (ROCE)	7.38%	0.87%	-5.72%	6.97%	14.31%	7.56%	-4.10%	20.03%	17.04%	14.69%	8.25%
Return on Equity Simple (ROE_SIMPLE)	1.76%	0.00%	0.16%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	1.04	0.12	-0.59	1.02	2.12	1.08	-0.65	2.85	2.51	2.16	1.14
NOPAT Margin	3.27%	0.39%	-1.85%	3.02%	6.00%	3.19%	-1.88%	7.91%	6.88%	5.97%	3.39%
Net Nonoperating Expense Percent (NNEP)	1.07%	0.17%	1.60%	0.86%	1.04%	0.56%	-1.37%	0.84%	1.06%	0.64%	0.56%
Return On Investment Capital (ROIC_SIMPLE)	-	0.15%	-0.72%	1.16%	2.54%	1.32%	-0.78%	3.52%	3.29%	2.81%	1.46%
Cost of Revenue to Revenue	51.06%	47.40%	48.51%	50.54%	46.08%	46.18%	44.79%	44.80%	42.94%	43.60%	41.57%
SG&A Expenses to Revenue	34.29%	36.19%	42.80%	34.20%	36.18%	39.04%	44.12%	36.51%	39.54%	38.86%	43.95%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	43.62%	48.66%	54.13%	43.96%	44.68%	46.09%	53.43%	44.71%	46.62%	46.15%	53.71%
Earnings before Interest and Taxes (EBIT)	1.68	1.23	-0.84	1.79	3.26	2.63	0.59	3.82	3.76	3.76	1.67
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	4.77	4.40	2.08	4.85	6.43	6.07	3.93	7.18	7.06	7.13	4.95
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.94	4.27	3.47	2.72	2.57	3.12	2.05	2.40	3.81	3.18	3.18
Price to Tangible Book Value (P/TBV)	5.07	5.43	4.39	3.40	3.17	3.79	2.50	3.00	4.74	3.90	3.86
Price to Revenue (P/Rev)	1.65	1.78	1.42	1.12	1.08	1.33	0.82	0.94	1.50	1.27	1.31
Price to Earnings (P/E)	95.38	474.04	0.00	0.00	131.87	75.62	35.09	25.65	38.09	30.04	25.36
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.05%	0.21%	0.00%	0.00%	0.76%	1.32%	2.85%	3.90%	2.63%	3.33%	3.94%
Enterprise Value to Invested Capital (EV/IC)	2.80	3.11	2.59	2.05	2.05	2.51	1.70	1.95	3.07	2.70	2.68
Enterprise Value to Revenue (EV/Rev)	1.92	2.00	1.65	1.39	1.28	1.51	1.02	1.12	1.64	1.39	1.43
Enterprise Value to EBITDA (EV/EBITDA)	14.40	15.14	13.46	11.15	9.60	10.46	6.59	6.63	9.56	7.86	7.76
Enterprise Value to EBIT (EV/EBIT)	62.51	62.71	63.43	46.46	31.32	29.70	16.96	15.20	21.46	16.68	15.70
Enterprise Value to NOPAT (EV/NOPAT)	112.38	130.93	882.58	230.12	73.20	63.56	34.78	26.27	36.38	26.74	23.59
Enterprise Value to Operating Cash Flow (EV/OCF)	21.15	22.47	17.93	15.46	9.92	9.92	6.41	5.89	9.19	8.15	8.65
Enterprise Value to Free Cash Flow (EV/FCFF)	6,329.19	144.18	64.92	0.00	53.54	58.00	45.71	11.77	16.51	13.68	13.87
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.63	0.56	0.57	0.64	0.50	0.41	0.52	0.48	0.38	0.34	0.33
Long-Term Debt to Equity	0.63	0.56	0.57	0.64	0.50	0.41	0.52	0.48	0.38	0.34	0.33
Financial Leverage	0.67	0.62	0.65	0.68	0.56	0.48	0.52	0.55	0.43	0.35	0.39
Leverage Ratio	2.03	2.02	2.06	2.04	1.94	1.88	1.95	1.94	1.84	1.78	1.78
Compound Leverage Factor	1.35	1.19	3.18	1.49	1.66	1.62	0.84	1.75	1.68	1.65	1.51
Debt to Total Capital	38.82%	35.75%	36.41%	38.98%	33.51%	29.32%	34.23%	32.58%	27.40%	25.50%	25.06%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	38.82%	35.75%	36.41%	38.98%	33.51%	29.32%	34.23%	32.58%	27.40%	25.50%	25.06%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	61.18%	64.25%	63.59%	61.02%	66.49%	70.68%	65.77%	67.43%	72.60%	74.50%	74.94%
Debt to EBITDA	2.00	1.75	1.91	2.12	1.58	1.23	1.35	1.12	0.86	0.78	0.75
Net Debt to EBITDA	1.99	1.73	1.86	2.11	1.56	1.20	1.28	1.09	0.82	0.65	0.67
Long-Term Debt to EBITDA	2.00	1.75	1.91	2.12	1.58	1.23	1.35	1.12	0.86	0.78	0.75
Debt to NOPAT	15.59	15.11	125.40	43.81	12.02	7.47	7.12	4.42	3.29	2.64	2.27
Net Debt to NOPAT	15.51	14.99	121.96	43.62	11.85	7.31	6.75	4.30	3.14	2.21	2.03
Long-Term Debt to NOPAT	15.59	15.11	125.40	43.81	12.02	7.47	7.12	4.42	3.29	2.64	2.27
Altman Z-Score	3.04	3.28	2.64	2.26	2.50	3.12	2.13	2.58	3.81	3.43	3.68
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.08	1.95	1.87	2.07	1.98	1.82	2.21	2.19	1.90	1.80	2.14
Quick Ratio	1.37	1.28	1.23	1.35	1.37	1.23	1.59	1.59	1.35	1.29	1.52
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1.01	-0.05	2.41	-0.53	2.97	1.38	-1.62	10	10	9.26	7.20
Operating Cash Flow to CapEx	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	-1.80	-0.11	5.30	-1.09	6.25	3.83	-4.81	27.33	30.82	35.63	28.24
Operating Cash Flow to Interest Expense	7.57	9.26	0.83	4.77	20.68	21.97	5.30	18.79	25.74	27.41	3.80
Operating Cash Flow Less CapEx to Interest Expense	9.72	10.35	3.18	6.02	21.75	25.60	7.15	20.82	28.08	29.69	5.45
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.22	1.24	1.23	1.22	1.28	1.31	1.32	1.34	1.38	1.41	1.40
Accounts Receivable Turnover	6.91	6.85	6.57	6.44	6.29	6.58	6.19	6.11	5.99	6.51	5.95
Inventory Turnover	11.41	11.17	10.56	10.19	9.99	9.97	10.45	10.17	10.25	10.59	10.33
Fixed Asset Turnover	29.10	28.90	29.55	30.52	32.61	32.30	33.75	35.05	37.32	38.82	39.89
Accounts Payable Turnover	8.75	7.67	7.32	8.29	7.73	7.22	7.10	6.60	6.65	6.11	6.84
Days Sales Outstanding (DSO)	52.84	53.25	55.59	56.70	58.02	55.46	58.94	59.76	60.90	56.05	61.35
Days Inventory Outstanding (DIO)	32.00	32.68	34.57	35.83	36.54	36.61	34.93	35.90	35.62	34.45	35.34
Days Payable Outstanding (DPO)	41.72	47.61	49.90	44.04	47.24	50.56	51.40	55.27	54.86	59.74	53.33
Cash Conversion Cycle (CCC)	43.12	38.32	40.27	48.49	47.32	41.51	42.47	40.38	41.65	30.76	43.36
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	84	81	81	88	83	81	82	80	75	74	76
Invested Capital Turnover	1.48	1.55	1.54	1.49	1.59	1.66	1.68	1.67	1.78	1.86	1.80
Increase / (Decrease) in Invested Capital	2.06	0.18	-3.01	1.54	-0.86	-0.31	0.96	-7.35	-7.66	-7.10	-6.06
Enterprise Value (EV)	235	252	211	179	170	203	140	157	232	199	204
Market Capitalization	203	223	182	145	143	180	113	131	212	182	187
Book Value per Share	$2.44	$2.47	$2.47	$2.51	$2.60	$2.71	$2.62	$2.60	$2.72	$2.82	$2.91
Tangible Book Value per Share	$1.90	$1.94	$1.95	$2.01	$2.12	$2.23	$2.15	$2.08	$2.19	$2.30	$2.39
Total Capital	84	81	82	88	83	81	84	81	76	77	78
Total Debt	33	29	30	34	28	24	29	26	21	20	20
Total Long-Term Debt	33	29	30	34	28	24	29	26	21	20	20
Net Debt	32	29	29	34	28	23	27	26	20	16	18
Capital Expenditures (CapEx)	-1.21	-0.55	-1.08	-0.61	-0.51	-1.31	-0.62	-0.76	-0.78	-0.59	-0.42
Debt-free, Cash-free Net Working Capital (DFCFNWC)	15	15	14	17	16	14	18	18	16	13	17
Debt-free Net Working Capital (DFNWC)	15	15	15	17	17	15	19	19	17	16	20
Net Working Capital (NWC)	15	15	15	17	17	15	19	19	17	16	20
Net Nonoperating Expense (NNE)	0.35	0.05	0.52	0.30	0.31	0.15	-0.39	0.25	0.25	0.13	0.12
Net Nonoperating Obligations (NNO)	32	29	29	34	28	23	27	26	20	16	18
Total Depreciation and Amortization (D&A)	3.09	3.17	2.92	3.05	3.16	3.44	3.34	3.36	3.31	3.37	3.27
Debt-free, Cash-free Net Working Capital to Revenue	12.44%	11.67%	11.24%	13.05%	12.27%	10.36%	12.97%	13.02%	11.27%	9.04%	12.23%
Debt-free Net Working Capital to Revenue	12.57%	11.85%	11.89%	13.17%	12.56%	10.75%	14.07%	13.54%	11.95%	11.26%	13.71%
Net Working Capital to Revenue	12.57%	11.85%	11.89%	13.17%	12.56%	10.75%	14.07%	13.54%	11.95%	11.26%	13.71%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.03	$0.01	($0.05)	$0.03	$0.08	$0.05	($0.01)	$0.12	$0.11	$0.10	$0.05
Adjusted Weighted Average Basic Shares Outstanding	21.10M	21.02M	21.23M	21.30M	21.29M	21.27M	21.13M	20.81M	20.41M	20.66M	20.21M
Adjusted Diluted Earnings per Share	$0.03	$0.01	($0.05)	$0.03	$0.08	$0.05	($0.01)	$0.12	$0.11	$0.09	$0.05
Adjusted Weighted Average Diluted Shares Outstanding	21.72M	21.65M	21.23M	21.71M	21.65M	21.71M	21.13M	21.06M	20.95M	21.10M	20.89M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	21.18M	0.00	21.30M	21.32M	21.26M	21.01M	20.98M	20.43M	20.34M	20.22M	20.18M
Normalized Net Operating Profit after Tax (NOPAT)	1.04	0.88	-0.59	1.02	2.12	1.83	0.43	2.85	2.51	2.16	1.14
Normalized NOPAT Margin	3.27%	2.75%	-1.85%	3.02%	6.00%	5.41%	1.25%	7.91%	6.88%	5.97%	3.39%
Pre Tax Income Margin	3.51%	2.29%	-4.06%	3.88%	7.89%	6.69%	0.73%	9.57%	9.39%	9.65%	4.21%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.99	2.45	-1.85	3.70	6.85	7.27	1.75	10.24	11.38	14.45	6.56
NOPAT to Interest Expense	1.85	0.25	-1.30	2.10	4.45	2.99	-1.94	7.64	7.61	8.32	4.48
EBIT Less CapEx to Interest Expense	5.14	3.53	0.51	4.96	7.92	10.90	3.61	12.27	13.73	16.73	8.20
NOPAT Less CapEx to Interest Expense	4.00	1.33	1.06	3.36	5.52	6.62	-0.09	9.67	9.96	10.60	6.12
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	27.89%	17.55%	0.00%	77.32%	66.11%	50.32%	127.74%	143.77%	158.62%	148.92%	98.38%

Financials Breakdown Chart

InfuSystem Financials - Frequently Asked Questions

According to the most recent income statement we have on file, InfuSystem's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

InfuSystem's net income appears to be on an upward trend, with a most recent value of $6.63 million in 2025, rising from $2.79 million in 2015. The previous period was $2.35 million in 2024. Find out what analysts predict for InfuSystem in the coming months.

InfuSystem's total operating income in 2025 was $11.92 million, based on the following breakdown:

Total Gross Profit: $80.30 million
Total Operating Expenses: $68.38 million

Over the last 10 years, InfuSystem's total revenue changed from $70.54 million in 2015 to $143.44 million in 2025, a change of 103.3%.

InfuSystem's total liabilities were at $43.23 million at the end of 2025, a 6.2% decrease from 2024, and a 4.0% decrease since 2015.

In the past 10 years, InfuSystem's cash and equivalents has ranged from $165 thousand in 2022 to $9.65 million in 2020, and is currently $3.19 million as of their latest financial filing in 2025.

Over the last 10 years, InfuSystem's book value per share changed from 2.24 in 2015 to 2.82 in 2025, a change of 26.1%.

Related Companies

Financial statements for NYSE:INFU last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

InfuSystem (INFU) Financials

Financials Breakdown Chart

InfuSystem Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

InfuSystem (INFU) Financials

Annual Income Statements for InfuSystem

Quarterly Income Statements for InfuSystem

Annual Cash Flow Statements for InfuSystem

Quarterly Cash Flow Statements for InfuSystem

Annual Balance Sheets for InfuSystem

Quarterly Balance Sheets for InfuSystem

Annual Metrics And Ratios for InfuSystem

Quarterly Metrics And Ratios for InfuSystem

Financials Breakdown Chart

InfuSystem Financials - Frequently Asked Questions

When does InfuSystem's fiscal year end?

How has InfuSystem's net income changed over the last 10 years?

What is InfuSystem's operating income?

How has InfuSystem's revenue changed over the last 10 years?

How much debt does InfuSystem have?

How much cash does InfuSystem have?

How has InfuSystem's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools